Novo Nordisk's Diabetes Drug Outshines Ozempic: Buy?
A new diabetes drug from Novo Nordisk could change the GLP-1 landscape. This deep dive breaks down what investors sho...
There are effective ways to optimize your budget based on expenses. Discover techniques that help you manage your finances better.
19,588 articlesA new diabetes drug from Novo Nordisk could change the GLP-1 landscape. This deep dive breaks down what investors sho...
Biotech investors chase game-changing tech, but CRISPR Therapeutics carries real regulatory milestones and execution ...
Seven Hills SEVN 2025 Q4 earnings reveal growth signals, margin dynamics, and a clear plan for 2026. This deep dive b...
A Tuesday surge in Uber stock sparked curiosity among investors. This article dives into the catalysts, profitability...
A wave of fresh analyst upgrades and price-target bumps hits NVIDIA, Alphabet, and other big names as markets start t...
A major U.S. move targets a broker accused of trading stolen cyber tools, signaling a new turn in sanctions enforceme...
Jimmy Wales’ Bitcoin bubble call collides with rising on-chain activity and bullish Polymarket bets. Traders see dive...
Wix has endured a brutal stock down year, dropping roughly 70% as growth worries and macro headwinds hit software nam...
Markets have celebrated a long rally, but chair nominee kevin warsh's real test may lie in credibility, independence,...
When a stimulus move hits a niche chip maker like Tower Semiconductor, investors ask what really caused it. This arti...
Alibaba’s AI models project sharp upside for XRP, Bitcoin and Ethereum by the end of 2026. The forecasts come as mark...
Ripple reveals an AI-driven security upgrade for the XRP Ledger after a batch-transaction bug. The move aims to harde...